TITLE

Elite Model for the Generation of Induced Pluripotent Cancer Cells (iPCs)

AUTHOR(S)
Lai, Jason; Kong, Chiou Mee; Mahalingam, Dashayini; Xie, Xiaojin; Wang, Xueying
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The inefficiency of generating induced pluripotent somatic cells (iPS) engendered two contending models, namely the Stochastic model and Elite model. Although the former is more favorable to explain the inherent inefficiencies, it may be fallible to extrapolate the same working model to reprogramming of cancer cells. Indeed, tumor cells are known to be inherently heterogeneous with respect to distinctive characteristics thus providing a suitable platform to test whether the reprogramming process of cancer cells is biased. Here, we report our observations that all randomly picked induced pluripotent cancer cells (iPCs) established previously do not possess mutations known in the parental population. This unanticipated observation is most parsimoniously explained by the Elite model, whereby putative early tumor progenies were selected during induction to pluripotency.
ACCESSION #
87624849

 

Related Articles

  • KSR-Based Medium Improves the Generation of High-Quality Mouse iPS Cells. Liu, Kai; Wang, Fang; Ye, Xiaoying; Wang, Lingling; Yang, Jiao; Zhang, Jingzhuo; Liu, Lin // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Induced pluripotent stem (iPS) cells from somatic cells have great potential for regenerative medicine. The efficiency in generation of iPS cells has been significantly improved in recent years. However, the generation of high-quality iPS cells remains of high interest. Consistently, we...

  • Discovery Pipeline. Ritter, Amy // BioPharm International;Dec2012, Vol. 25 Issue 12, p7 

    The article offers information on the study that was published in the November 21, 2012 issue of "Cell" journal, regarding the mechanisms in the reprogramming of somatic cells into induced pluripotent stem cells (IPSCs) which are used for disease modeling.

  • Development of a New Approach to Aid in Visual Identification of Murine iPS Colonies Using a Fuzzy Logic Decision Support System. Bassaneze, Vinicius; Sacramento, Chester Bittencourt; Freire, Rodolfo; Alencar, Patrícia Fernandes De; Ortega, Neli Regina Siqueira; Krieger, Jose Eduardo // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    The a priori identification of induced pluripotent stem cells remains a challenge. Being able to quickly identify the most embryonic stem cell-similar induced pluripotent stem cells when validating results could help to reduce costs and save time. In this context, tools based on non-classic...

  • Human evolution: Reprogrammed cells dissect ape retrotransposition. Burgess, Darren J. // Nature Reviews Genetics;Dec2013, Vol. 14 Issue 12, p824 

    The article focuses on a study which aims to use induced pluripotent stem cells (iPSCs) of primates to determine differential regulation of long interspersed element 1 (LINE-1) retrotransposons between humans and non-human primates (NHPs). It notes that the characterization of biological...

  • Announcement: Sarcomeric cardiomyopathies: from bedside to bench and back. Carrier, Lucie; van der Velden, Jolanda // Cardiovascular Research;Jun2014, Vol. 102 Issue 3, pNP 

    No abstract available.

  • Cure of ADPKD by Selection for Spontaneous Genetic Repair Events in Pkd1-Mutated iPS Cells. Li-Tao Cheng; Nagata, Shogo; Hirano, Kunio; Yamaguchi, Shinpei; Horie, Shigeo; Ainscough, Justin; Tada, Takashi // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Induced pluripotent stem cells (iPSCs) generated by epigenetic reprogramming of personal somatic cells have limited therapeutic capacity for patients suffering from genetic disorders. Here we demonstrate restoration of a genomic mutation heterozygous for Pkd1 (polycystic kidney disease 1)...

  • Characterization and Molecular Profiling of PSEN1 Familial Alzheimer's Disease iPSC-Derived Neural Progenitors. Sproul, Andrew A.; Jacob, Samson; Pre, Deborah; Kim, Soong Ho; Nestor, Michael W.; Navarro-Sobrino, Miriam; Santa-Maria, Ismael; Zimmer, Matthew; Aubry, Soline; Steele, John W.; Kahler, David J.; Dranovsky, Alex; Arancio, Ottavio; Crary, John F.; Gandy, Sam; Noggle, Scott A. // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Presenilin 1 (PSEN1) encodes the catalytic subunit of γ-secretase, and PSEN1 mutations are the most common cause of early onset familial Alzheimer's disease (FAD). In order to elucidate pathways downstream of PSEN1, we characterized neural progenitor cells (NPCs) derived from FAD mutant PSEN1...

  • Epigenetics: Methylation reboot. Seton-Rogers, Sarah // Nature Reviews Cancer;May2013, Vol. 13 Issue 5, p292 

    The article discusses research being done on DNA methylation. It references the study "Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner," by S. H. Stricker and colleagues in the 2013 issue. It adds that...

  • miR-128 represses L1 retrotransposition by binding directly to L1 RNA. Hamdorf, Matthias; Idica, Adam; Zisoulis, Dimitrios G; Gamelin, Lindsay; Martin, Charles; Sanders, Katie J; Pedersen, Irene M // Nature Structural & Molecular Biology;Oct2015, Vol. 22 Issue 10, p824 

    Long interspersed element 1 (LINE-1 or L1) retrotransposons compose 17% of the human genome. Active L1 elements are capable of replicative transposition (mobilization) and can act as drivers of genetic diversity. However, this mobilization is mutagenic and may be detrimental to the host, and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics